EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities

Dayuan Zheng, Tong Chu, Dongfan Yang, Shaokui Liang, Lu Yang, Yanchao Yang, Kuanyun Zhang, Wenzhe Ma iD

Advanced Biology · 2025

DOI: 10.1002/adbi.202500460 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Biology, 2025. Verfasst von Dayuan Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SA…. Hauptthemen laut MEDLINE: Ferroptosis, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: Science and Technology Development Fund, Fundo para o Desenvolvimento das Ciências e da Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC), an Epstein‐Barr virus (EBV)‐driven malignancy with geographic prevalence in Asia, faces therapeutic challenges due to acquired resistance. Ferroptosis—an iron‐dependent cell death pathway driven by lipid peroxidation—emerges as a critical regulator of NPC pathobiology. This review synthesizes how ferroptosis suppression promotes NPC tumor growth, metastasis, and therapy resistance. Key mechanisms include: 1. EBV‐mediated activation of p62‐Keap1‐NRF2/GPX4 and GPX4‐TAK1 axes conferring chemo/radioresistance; 2. Extracellular vesicle (EV)‐mediated transfer of ITGB3 or SCARB1 reprogramming tumor‐associated macrophages (TAMs) and inhibiting ferroptosis in circulating cells; 3. Metabolic rewiring (e.g., CAPRIN2/HMGCR, P4HA1/HMGCS1) enhancing metastasis. Additionally, ferroptosis induction via radiotherapy, natural compounds (solasodine, luteolin), repurposed drugs (disulfiram/copper), or nanotechnology synergizes with immunotherapy by promoting lipid peroxidation and reversing EBV‐mediated immune evasion. Targeting ferroptosis regulators (SLC7A11, GPX4, FTO, CD38) overcomes resistance, positioning ferroptosis modulation as a transformative strategy for NPC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNasopharyngeal CarcinomaNasopharyngeal NeoplasmsDrug Resistance, NeoplasmHumansAnimalsLipid Peroxidation

Stichwörter der Autor:innen

chemotherapy resistanceferroptosisnasopharyngeal carcinomaradiotherapy resistancetreatment

Autor:innen und Institutionen

  • State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Macau SAR, 999078, China.
  • Zhuhai MUST Science and Technology Research Institute, Macau University of Science and Technology, Hengqin Guangdong-Macao In-Depth Cooperation Zone, Guangdong, 519099, China.

ORCID-Profile: Wenzhe Ma

Förderung

  • Science and Technology Development Fund
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia

Zitieren

APA

Zheng, D., Chu, T., Yang, D., Liang, S., Yang, L., Yang, Y., Zhang, K., & Ma, W. (2025). Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities. Advanced Biology. https://doi.org/10.1002/adbi.202500460

Vancouver

Zheng D, Chu T, Yang D, Liang S, Yang L, Yang Y, et al. Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities. Advanced Biology. 2025. doi:10.1002/adbi.202500460

BibTeX
@article{Zheng2025,
  author = {Zheng, Dayuan and Chu, Tong and Yang, Dongfan and Liang, Shaokui and Yang, Lu and Yang, Yanchao and Zhang, Kuanyun and Ma, Wenzhe},
  title = {Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities},
  journal = {Advanced Biology},
  year = {2025},
  doi = {10.1002/adbi.202500460}
}
Kostenlos starten →